Evidence map›Paper›PMID 29916740›Full record

ArticleDiabetes technology & therapeutics2018

Preserving Skin Integrity with Chronic Device Use in Diabetes.

Laurel H Messer, Cari Berget, Christie Beatson, Sarit Polsky, Gregory P Forlenza

Open access · hybridAbstract read
In one paragraph

Article in Diabetes technology & therapeutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 5 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 5 syntheses or guidelines pooled it, 109 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Guideline
  5. Pooled it
  6. Trial
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Advances in Continuous Glucose Monitoring: Clinical Applications.Endocrinology and metabolism (Seoul, Korea) · 2025
    Review
  13. Review
  14. Review
  15. Review
  16. Pneumothorax suspected secondary to continuous glucose monitor placement in a dog.The Canadian veterinary journal = La revue veterinaire canadienne · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Laurel H MesserBarbara Davis Center for Childhood Diabetes, University of Colorado Denver , Aurora, Colorado.
Cari BergetBarbara Davis Center for Childhood Diabetes, University of Colorado Denver , Aurora, Colorado.
Christie BeatsonBarbara Davis Center for Childhood Diabetes, University of Colorado Denver , Aurora, Colorado.
Sarit PolskyBarbara Davis Center for Childhood Diabetes, University of Colorado Denver , Aurora, Colorado.
Gregory P ForlenzaBarbara Davis Center for Childhood Diabetes, University of Colorado Denver , Aurora, Colorado.
University of Colorado Denver · US

Funding

K12 Career DevelopmentK12DK094712 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI STECK, ANDREA · 2011 to 2021
$4.5M
NIDDK NIH HHS K12 DK094712
6 · The paper itself

Abstract

Skin integrity and diabetes device placement are ongoing concerns for people with diabetes who utilize continuous glucose monitors (CGMs) and continuous subcutaneous insulin infusion pumps. This is especially significant for individuals with skin sensitivities, pediatric patients, and those who use devices chronically. Dermatological complications are often cited as a barrier to device use and a reason for device discontinuation. Furthermore, it is a frequent topic of discussion in diabetes follow-up visits, although little evidence-based literature exists to guide providers in managing skin integrity issues. The purpose of this article is to review current literature related to the prevalence of dermatological issues with insulin pumps and CGM, discuss published solutions to skin irritation, and to share the consolidated experience of our large academic diabetes clinic to address placement, prophylactic skin care, adhesives, removal, and skin healing with diabetes device use. Recommendations for targeted studies, increased surveillance, and development of new adhesive compounds are suggested to reduce the burden of device wear for management of diabetes.

Indexed as

SkinBlood GlucoseBlood Glucose Self-MonitoringDiabetes Mellitus, Type 1EczemaHumansInsulin Infusion SystemsBlood GlucoseCGMCSIIDermatitisDiabetesHypersensitivitySkin care

Identifiers

PMID29916740
PMCPMC6011799
OpenAlexW2808747546

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.